Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-004565

CONCERT PHARMACEUTICALS, INC. · CNCE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jan 17, 2018
Accepted (ET)
Jan 19, 2018 · 4:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2,F3Jan 17, 2018S5,000$18.95D51,946ISee Footnote
Common StockF4,F5Jan 17, 2018S5,000$19.03D72,405ISee Footnote
Common StockF6,F3Jan 18, 2018S5,000$19.36D46,946ISee Footnote
Common StockF7,F5Jan 18, 2018S5,000$19.43D67,405ISee Footnote
Common StockF8,F3Jan 19, 2018S5,000$19.66D41,946ISee Footnote
Common StockF9,F5Jan 19, 2018S5,000$19.65D62,405ISee Footnote
Common Stockholding———286,975D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses